Hepatotoxicity of Antiretrovirals

This publication has 85 references indexed in Scilit:

• Short Communication: Liver Toxicity of Lopinavir-Containing Regimens in HIV-Infected Patients with or without Hepatitis C Coinfection
  AIDS Research and Human Retroviruses, 2004
• Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine
  HIV Research & Clinical Practice, 2003
• Short Communication: Interactions between Nevirapine Plasma Levels, Chronic Hepatitis C, and the Development of Liver Toxicity in HIV-Infected Patients
  AIDS Research and Human Retroviruses, 2003
• A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999
  Clinical Infectious Diseases, 2002
• Review of the Effect of Highly Active Antiretroviral Therapy on Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus and HCV Coinfection
  Clinical Infectious Diseases, 2002
• Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections
  Hepatology, 2002
• Symptomatic Lactic Acidosis in Hospitalized Antiretroviral‐Treated Patients with Human Immunodeficiency Virus Infection: A Report of 12 Cases
  Clinical Infectious Diseases, 2001
• Drug–Induced Liver Injury: Mechanisms and Test Systems
  Hepatology, 2001
• Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine
  Clinical Infectious Diseases, 2000
• Change in Transaminases in Hepatitis C Virus- and HIV-Coinfected Patients after Highly Active Antiretroviral Therapy: Differences between Complete and Partial Virologic Responders?
  AIDS Research and Human Retroviruses, 2000